FedQuery

Biolegend, INC.

UEI WVJUG294HEM6 · CA · SAM.gov record ↗

$260K
FY2025 obligations
14
Contract awards
Aug 21, 2020
First action
May 13, 2026
Latest action

Obligations by agency

  • Department Of Health And Human Services$260K

Obligations by NAICS

Monthly obligations

Nov 24
Jan 25
Mar 25
Apr 25
May 25
Aug 25
Sep 25
Mar 26
May 26

Contracts ending within 18 months (recompete watch)

  • 75N98026P00452 ↗$16K

    TOTALSEQ-D HUMAN HEME ONCOLOGY COCKTAIL BIOLEGEND INC:1135351 [26-004804]

    Ends
    Sep 29, 2026
    Started
    May 6, 2026
    Agency
    National Institutes Of Health
    NAICS
    325414
  • 75N98026P00519 ↗$23K

    MISSION BIO TAPESTRI SINGLE CELL DNA SEQUENCING BIOLEGEND INC:1135351 [26-004813]

    Ends
    Nov 11, 2026
    Started
    May 12, 2026
    Agency
    National Institutes Of Health
    NAICS
    325414

Largest awards

  • 75N93025P00221 ↗$57K

    BIOLEGEND (AMBIS #2251721) BIOLOGICAL PRODUCTS, REAGENTS

    Ends
    Mar 30, 2025
    Started
    Jan 5, 2025
    Agency
    National Institutes Of Health
    NAICS
    325414
  • 75N92025P00327 ↗$49K

    BIOLEGEND TOTALSEQ-C REAGENTS

    Ends
    Oct 8, 2025
    Started
    Sep 9, 2025
    Agency
    National Institutes Of Health
    NAICS
    325414
  • 75N92025P00301 ↗$23K

    [25-012698] THE LAB REQUIRES ANTIBODIES IN ORDER TO FOR IMMUNE CELL DISTRIBUTION AND FUNCTION IN SLEEP STUDY.

    Ends
    Nov 4, 2025
    Started
    Aug 5, 2025
    Agency
    National Institutes Of Health
    NAICS
    325414
  • 75N98026P00519 ↗$23K

    MISSION BIO TAPESTRI SINGLE CELL DNA SEQUENCING BIOLEGEND INC:1135351 [26-004813]

    Ends
    Nov 11, 2026
    Started
    May 12, 2026
    Agency
    National Institutes Of Health
    NAICS
    325414
  • 75N98026P00452 ↗$16K

    TOTALSEQ-D HUMAN HEME ONCOLOGY COCKTAIL BIOLEGEND INC:1135351 [26-004804]

    Ends
    Sep 29, 2026
    Started
    May 6, 2026
    Agency
    National Institutes Of Health
    NAICS
    325414
  • 75N93025P00987 ↗$16K

    BIOLEGEND, ANTIBODIES, SEE QUOTE- 1XAJL033125-NIAID

    Ends
    Jun 29, 2025
    Started
    May 13, 2025
    Agency
    National Institutes Of Health
    NAICS
    325414
  • 75N91025P00304 ↗$15K

    ANTIBODIES FOR CLINICAL TRIAL PROTOCOL, WE WILL BE PERFORMING MULTI-PARAMETER FLOW-CYTOMETRIC ANALYSES FOR CIRCULATING IMMUNE SUBSETS ON OVER 230 CLINICAL SAMPLES, REQUIRING 30 DIFFERENT ANTIBODIES. THIS IS TO PROVIDE THE MAJORITY OF PHARMACODYNAMIC

    Ends
    May 20, 2025
    Started
    Mar 30, 2025
    Agency
    National Institutes Of Health
    NAICS
    334516
  • 75N90025P00094 ↗$15K

    25-001224 BIOLEGEND INC REAGENTS AND KITS

    Ends
    May 27, 2025
    Started
    Nov 27, 2024
    Agency
    National Institutes Of Health
    NAICS
    325414
  • 75N95D25P00107 ↗$14K

    BIOLOGICAL AND REAGENT MATERIAL - BIOLEGEND FLOW CYTOMETER ANTIBODIES

    Ends
    Oct 20, 2025
    Started
    Sep 21, 2025
    Agency
    National Institutes Of Health
    NAICS
    325414
  • 75N92025P00145 ↗$13K

    [25-007798] LABS REQUIRE ANTIBODIES AND KITS FOR CELL ISOLATION IN ORDER TO FURTHER IDENTIFY CERTAIN CELLS THAT MAY AFFECT THE IMMUNE SYSTEM.

    Ends
    Jun 30, 2025
    Started
    Apr 1, 2025
    Agency
    National Institutes Of Health
    NAICS
    325414
  • 75N92025P00110 ↗$11K

    [25-007670] NHLBI DIR CCMPB REQUIRES ANTIBODIES IN ORDER TO ASSESS ANTIGENS ON THE SURFACE WITHIN BLOOD SAMPLES BY FLOW CYTOMETRY

    Ends
    May 19, 2025
    Started
    Mar 19, 2025
    Agency
    National Institutes Of Health
    NAICS
    325414
  • 75N92025P00372 ↗$10K

    [25-014521]NIH NHLBI LABORATORY OF IMMUNE REGULATORY GENOMICS AND EPIGENOMICS REQUIRES TOTAL SEQ ANTIBODY COCKTAILS (MIXTURES OF ANTIBODIES CONJUGATED TO DNA OLIGONUCLEOTIDES FOR THE PREPARATION OF MULTIOMIC SINGLE CELL LIBRARIES) IN ORDER TO ADD IMM

    Ends
    Nov 10, 2025
    Started
    Sep 10, 2025
    Agency
    National Institutes Of Health
    NAICS
    325414
  • 75N93021P01445 ↗$-1

    TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.

    Ends
    Oct 16, 2021
    Started
    Sep 16, 2021
    Agency
    National Institutes Of Health
    NAICS
    325414
  • 75N93020P01171 ↗$-3K

    BRILLIANT VIOLET ANTI-HUMAN ANTIBODIES

    Ends
    Nov 28, 2022
    Started
    Aug 21, 2020
    Agency
    National Institutes Of Health
    NAICS
    325413